Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Letters

• Publication date

  2007-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANLET.2006.03.014PMID 16677755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.

  2006cited by this paper
• TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.

  2006cited by this paper
• The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.

  2005cited by this paper
• Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk

  2005cited by this paper
• Single nucleotide polymorphisms for DNA repair genes in breast cancer patients.

  2005cited by this paper
• Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.

  2004cited by this paper
• Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

  2004cited by this paper
• XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk

  2004cited by this paper
• ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

  2004cited by this paper
• DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.

  2004cited by this paper
• DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer

  2004cited by this paper
• Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma.

  2004cited by this paper
• Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays.

  2003cited by this paper
• Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome

  2003cited by this paper
• Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population

  2003cited by this paper
• Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis.

  2002cited by this paper
• The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population

  2002cited by this paper
• XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha.

  2002cited by this paper
• Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases.

  2002cited by this paper
• Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes.

  2002cited by this paper
• Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population.

  2002cited by this paper
• DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.

  2002cited by this paper
• Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.

  2001cited by this paper
• XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ.

  2001cited by this paper
• Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.

  2001cited by this paper
• Genetic polymorphisms in DNA repair genes and risk of lung cancer.

  2001cited by this paper
• "Other" breast cancer susceptibility genes: searching for more holy grail.

  2001cited by this paper
• Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited.

  2001cited by this paper
• XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

  2001cited by this paper
• Chapter 6: Estrogen Metabolism by Conjugation

  2000cited by this paper
• XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.

  2000cited by this paper
• XPD polymorphisms: effects on DNA repair proficiency.

  2000cited by this paper
• XPD / ERCC 2 polymorphisms and risk of head and neck cancer : a case-control analysis

  2000cited by this paper
• Variability in nucleotide excision repair and cancer risk: a review.

  2000cited by this paper
• Estrogen metabolism by conjugation.

  2000cited by this paper
• Low penetrance genes associated with increased risk for breast cancer.

  2000cited by this paper
• Ovarian cancer: an update for nursing practice.

  1999cited by this paper
• Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.

  1998influential reference
• Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH

  1998cited by this paper
• Loss of heterozygosity in human ovarian cancer on chromosome 19q.

  1997cited by this paper
• The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.

  1996cited by this paper
• DNA excision repair.

  1996cited by this paper
• p53 modulation of TFIIH–associated nucleotide excision repair activity

  1995cited by this paper
• The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor.

  1994cited by this paper
• Human xeroderma pigmentosum group D gene encodes a DMA helicase

  1993cited by this paper
• ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients.

  1992cited by this paper
• An efficient salt-chloroform extraction of DNA from blood and tissues.

  1989cited by this paper
• Androgen, estrogen and progestin binding in cytosols of benign gynecologic tumors and tumor-like lesions.

  1985cited by this paper
• Androgen, Estrogen and Progestin Binding in Cytosols of Benign Gynecologic Tumors and Tumor-Like Lesions

  1985cited by this paper
• Estrogen Receptors in Ovarian Epithelial Carcinoma

  1982cited by this paper
• The occurrence of multiple steroid hormone receptors in disease‐free and neoplastic human ovary

  1981cited by this paper

• Association between ERCC2 Lys751Gln, Asp312Asn, and Arg156Arg polymorphisms and gynecological cancer susceptibility: a meta-analysis

  2025cites this paper
• The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta‐analysis

  2022cites this paper
• PCR-RFLP Genotyping Analysis of TP53 Arg72Pro Polymorphism and Susceptibility to Esophageal Cancer in Pakistani Population

  2021cites this paper
• Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility

  2020influential citation
• Polymorphisms in DNA repair genes in lung cancer patients living in a coal-mining region.

  2019cites this paper
• Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: an updated meta-analysis with 4024 subjects

  2017cites this paper
• Genome-wide association studies and clinical outcome in ovarian cancer patients: validation in an independent cohort

  2017cites this paper
• Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer

  2016cites this paper
• Association between ERCC 2 rs 13181 and XRCC 2 rs 3218536 polymorphisms and the risk of ovarian cancer : a meta-analysis

  2016cites this paper
• TERAPIAS DIRIGIDAS COMO ESTRATÉGIA NO TRATAMENTO DE MANUTENÇÃO DO CANCRO DO OVÁRIO: revisão sistemática e metanálise de estudos clínicos randomizados

  2015influential citation
• Association among XRCC1, XRCC3, and BLHX gene polymorphisms and chromosome instability in lymphocytes from patients with endometriosis and ovarian cancer.

  2014cites this paper
• TP53 polymorphisms in sporadic North Indian breast cancer patients.

  2014cites this paper
• TP 53 Polymorphisms in Sporadic North Indian Breast Cancer Patients

  2014cites this paper
• Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility

  2013cites this paper
• Genetic susceptibility to sporadic ovarian cancer: a systematic review.

  2011cites this paper
• DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck.

  2011cites this paper
• Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.

  2011cites this paper
• Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population

  2009cites this paper
• DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

  2008cites this paper
• Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

  2008cites this paper
• Molecular Cancer Dna Repair Gene Ercc2 Polymorphisms and Associations with Breast and Ovarian Cancer Risk

  2007cites this paper